Research records indexed for Teriparatide

This page carries 12 of the 3,057 records that the literature query returned for Teriparatide, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 3,045 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is Teriparatide.

Indexed records

Records retrieved for Teriparatide, newest first
RecordYearStudy typeModeln as statedWhat it reported
An injectable liposome-anchored teriparatide incorporated gallic acid-grafted gelatin hydrogel for osteoarthritis treatment pmid:372585102023Research Support, Non-U.S. Gov't, research-articlerodentNot statedIndexed as research support, non-u.s. gov't, research-article. study model from MeSH "Mice". subject headings: Osteoarthritis; Teriparatide; Gelatin; Liposomes; Hydrogels.
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial pmid:291294362018Research Support, Non-U.S. Gov't, Multicenter Studyhuman trialNot statedIndexed as research support, non-u.s. gov't, multicenter study. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Osteoporosis, Postmenopausal; Teriparatide; Radiography; Incidence; Bone Density.
Role of Weekly Teriparatide Administration in Osseous Union Enhancement within Six Months After Posterior or Transforaminal Lumbar Interbody Fusion for Osteoporosis-Associated Lumbar Degenerative Disorders: A Multicenter, Prospective Randomized Study pmid:282449062017Multicenter Study, Randomized Controlled Trialhuman trialNot statedIndexed as multicenter study, randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Lumbar Vertebrae; Osteoporosis; Pseudarthrosis; Teriparatide; Spinal Fusion.
Teriparatide for osteoporosis: importance of the full course pmid:269020942016review-article, ReviewotherNot statedIndexed as review-article, review. study model from MeSH "Humans" with no interventional publication type. subject headings: Bone And Bones; Osteoporosis; Teriparatide; Bone Density; Bone Density Conservation Agents.
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial pmid:261449082015Research Support, Non-U.S. Gov't, research-articlehuman trialNot statedIndexed as research support, non-u.s. gov't, research-article. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Osteoporosis, Postmenopausal; Teriparatide; Drug Therapy, Combination; Drug Administration Schedule; Follow-Up Studies.
Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial pmid:245171562014Research Support, Non-U.S. Gov't, research-articlehuman trialNot statedIndexed as research support, non-u.s. gov't, research-article. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Osteoporosis, Postmenopausal; Teriparatide; Procollagen; Drug Therapy, Combination; Bone Density.
Evaluation of teriparatide treatment in adults with osteogenesis imperfecta pmid:244634512014Research Support, Non-U.S. Gov't, research-articlehuman trialNot statedIndexed as research support, non-u.s. gov't, research-article. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Lumbar Vertebrae; Osteogenesis Imperfecta; Teriparatide; Recombinant Proteins; Tomography, X-Ray Computed.
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial pmid:236836002013Research Support, Non-U.S. Gov't, research-articlehuman trialNot statedIndexed as research support, non-u.s. gov't, research-article. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Osteoporosis, Postmenopausal; Teriparatide; Drug Combinations; Combined Modality Therapy; Area Under Curve.
Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective pmid:233541152013Comparative Study, Clinical Trialhuman trialNot statedIndexed as comparative study, clinical trial. study model from MeSH "Humans" with publication type "clinical trial". subject headings: Lumbar Vertebrae; Osteoporosis, Postmenopausal; Etidronic Acid; Teriparatide; Spinal Fusion.
Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk pmid:227233222012Research Support, Non-U.S. Gov't, Multicenter Studyhuman trialNot statedIndexed as research support, non-u.s. gov't, multicenter study. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Spine; Osteoporosis; Spinal Fractures; Teriparatide; Radiography.
The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years pmid:229913132012research-articleotherNot statedIndexed as research-article. study model from MeSH "Humans" with no interventional publication type. subject headings: Osteosarcoma; Bone Neoplasms; Osteoporosis; Parathyroid Hormone; Teriparatide.
Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study pmid:228722182012Controlled Clinical Trialhuman trialNot statedIndexed as controlled clinical trial. study model from MeSH "Humans" with publication type "controlled clinical trial". subject headings: Ilium; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Etidronic Acid; Teriparatide.

Where this page sits

Compound page: Teriparatide. Class: Endocrine and immune signalling peptides.

Retrieved 2026-10-12.

Sources

  1. PubChem Compound Summary for CID 16133850, Teriparatide. PubChem, National Library of Medicine (2026). pubchem:16133850
  2. Drugs@FDA application register query for this compound, 3 application(s) returned: ANDA213641, NDA211939, NDA021318. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:teriparatide
  3. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocrine reviews (2005). pmid:15769903
  4. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2003). pmid:14606504
  5. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2003). pmid:12510800
  6. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2004). pmid:15068497
  7. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Archives of internal medicine (2005). pmid:16087825
  8. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. The New England journal of medicine (2007). pmid:18003959
  9. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2010). pmid:19594305
  10. Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet (London, England) (2013). pmid:23683600
  11. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet (London, England) (2015). pmid:26144908
  12. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. Lancet (London, England) (2017). pmid:28755782
  13. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet (London, England) (2018). pmid:29129436

On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.

Related resources